evenfolio

Healthcare · NSE: VIJAYA

Vijaya Diagnostic Centre

Q2 FY27 earnings and concall highlights

Price as of 16 Nov 2026
1,487.50+5.49%

Q2 FY27 earnings call · Guided by management

Call held 4 Nov 2026 · Read the filing on NSEFiling

20​%Revenue growth · FY27Raju · Q&A · p. 8
₹155–160​CrCapex for hub and spoke expansionRaju · p. 7
15​%Revenue growth · three to five yearsRaju · Q&A · p. 8
42​%EBITDA margin · FY27Raju · Q&A · p. 10
M.Cap
₹15,321Cr
P/E
75.2×
1Y return
+40.28%
From 52W high
−6.7%

Highlights are read by AI from the company's filing and can contain mistakes. Check the source page linked to each line.

Share price

Results Q2 FY27, as filed · consolidated · ₹ Cr

Q2 FY27Q2 FY26YoYQ1 FY27QoQ
Revenue255202+26.7%231+10.6%
EBITDA11382+37.8%99+14.4%
EBITDA margin44.1%40.6%+355 bps42.7%+149 bps
PBTProfit before tax7958+37.0%71+12.0%
Net profit5943+37.4%53+12.0%
EPS (₹)5.764.20+37.1%5.15+11.8%

From the company's own results filing on NSE. Net profit is the owners' share. Growth and the dotted lines are worked out from the filed figures.

Guidance

Revenue growth · FY2720%Revenue growth of at least 20% seen as achievable for FY27
Revenue growth · long term15%Long-term revenue growth guided at above 15% a year for three to five years
EBITDA margin · FY2742%FY27 EBITDA margin expected at about 42% and above
Volume growth · long term8-10%Long-term volume growth: 8-10% from existing network, 3-3.5% from new centres
New stores · FY27-FY288 hubs8 hubs and 14 spokes to be launched by Q1 FY28
New stores · FY284-5 hubsAt least 4 to 5 hubs planned in FY28, including third Hyderabad flagship
New stores · long term4-5 hubsAt least four to five hubs a year expected across geographies
Capex · FY27-FY28Rs 155-160 CrExpansion capex estimated at about Rs 155-160 crore
CapexRs 20 CrNew Panjagutta central lab to start in next few months; capex about Rs 20 crore
Capex · PuneRs 18-20 CrPune Market Yard hub with central lab to cost about Rs 18-20 crore
Capex · Pune · FY28Rs 19 CrBuilding near Mayur Colony, Pune to be bought for about Rs 19 crore; hub in FY28

Price not seen as the driver of 15% long-term top-line growth

Narasimha Raju · Chief Financial Officer · Q&A · p. 9
“But going forward, price is not the driver for the top line growth of 15%.”

More figures from the call

Company · Guidance
2–3​hubsHub additions per geography per year · every year
“That is the reason why each geography we are adding two or three hubs every year, and then with a planned expansion we are going across these geographies.”
Narasimha Raju · Chief Financial Officerp. 21
Company · Capacity
2​hubsCentres commissioned · H1 FY27
“We have commissioned two hub centers and seven spoke centers across our network so far during the year, that is in the first half.”
Sunil Chandra Kondapally · Executive Directorp. 4
Company · Capacity
3​hubsHubs to be commissioned · H2 FY27
“Looking ahead, we expect to commission another three hubs in the second half of FY '27, followed by three additional hubs in Q1 FY '28, further strengthening our network and expanding our presence across key markets.”
Sunil Chandra Kondapally · Executive Directorp. 4
Company · Capex
₹9​CrLand purchase cost · next two years
“we have successfully completed the purchase of the Kadapa land in Tier-2 location in AP for approximately INR 9 crore, where we will be setting up a hub center in the next two years.”
Narasimha Raju · Chief Financial Officerp. 7

In short

  1. 01Management expects at least 20% revenue growth in FY27 and above 15% a year over three to five years.
  2. 02FY27 EBITDA margin is expected at about 42% or above; Q2 margin was 44.1%.
  3. 03Q2 revenue was about Rs 255 crore, up 26.7%, with volume growth of 16.5%.
  4. 048 hubs and 14 spokes are planned by Q1 FY28 at an estimated capex of Rs 155-160 crore.
  5. 05At least 4 to 5 hubs are planned in FY28, including a third Hyderabad flagship.
  6. 06A deal to buy Arya Wellness Centre in Guwahati is expected to close in about two months.
  7. 07Surplus cash stands at about Rs 355 crore.

Capex

Two CT machines upgraded to 160-slice cardiac CT

2​machines
Narasimha Raju · Chief Financial Officer · p. 7
“we have also upgraded two CT equipment across our network to high-end 160-slice cardiac CT, considering the increase in demand for high-end complex CTs.”

Second MRI may be added in Tirupati in the next six months

Narasimha Raju · Chief Financial Officer · p. 13
“It is doing fantastically good, and now we might add our second MRI in Tirupati in the next six months.”

Hyderabad: Omega 3T MRI being considered for third Hyderabad flagship

Narasimha Raju · Chief Financial Officer · p. 18
“Just to tell you, we are also planning whether we should install Omega 3T MRI, the one which we installed in JP Nagar, Bengaluru.”

Capacity

Hyderabad: Lease signed; third Hyderabad flagship expected in six to eight months

6–8​months
Narasimha Raju · Chief Financial Officer · p. 18
“We expect that in the next six to eight months, we will be opening our third flagship with state-of-the-art equipment.”

10 hubs added in FY26 versus 4 to 5 a year earlier

Narasimha Raju · Chief Financial Officer · p. 9
“last year alone in FY '26, we did 10 hubs compared to 4 to 5 earlier hubs that we used to execute.”

Network of about 168 centres: 51 hubs and 117 spokes

Narasimha Raju · Chief Financial Officer · p. 11
“Overall, as of now, we have close to 168 centers consisting of 51 hubs and 117 spokes,”

Hyderabad: Hyderabad has 100 centres, of which 19 are hubs

Narasimha Raju · Chief Financial Officer · p. 12
“Out of 100 centers in Hyderabad, 19 are hubs, balance are the spokes.”

Hyderabad: At least three to four more Hyderabad spokes to be commissioned this year

3–4​spokes
Dhiren Gala · Head · p. 18
“And we will be commissioning at least three to four more spokes in Hyderabad this year.”

Segments

Hyderabad: Hyderabad grew over 20% and Pune about 15.5% in Q2

Narasimha Raju · Chief Financial Officer · p. 5
“our Hyderabad business continued its strong performance, growing by over 20% year-on-year, while Pune also delivered an encouraging growth of approximately 15.5% year-on-year.”

Revenue mix: Hyderabad 67%, rest of AP/Telangana 20%, Pune 5%, West Bengal 5%

Narasimha Raju · Chief Financial Officer · p. 6
“In terms of geography-wise revenue contribution, Hyderabad accounted for 67%, rest of AP Telangana approximately 20%, Pune 5%, West Bengal 5%, and the remaining geographies accounted for the balance 3%.”

Pune: Pune network delivering double-digit growth for three to four quarters

Sunil Chandra Kondapally · Executive Director · p. 4
“We have also witnessed a meaningful turnaround in Pune with our network consistently delivering healthy double-digit growth over the past three to four quarters.”

West Bengal: Momentum in West Bengal as newer centres mature

Sunil Chandra Kondapally · Executive Director · p. 4
“We continue to see encouraging momentum in West Bengal as our newest centers gradually mature and brand awareness also strengthens.”

Hyderabad: Hyderabad revenue share expected to fall 3-4% a year as other markets grow

Sunil Chandra Kondapally · Executive Director · p. 10
“As we move forward, we will continue to see that the dependence on Hyderabad, that number will continue to come down maybe by a few percentage, 3% to 4% every year for sure, and other markets will increase their contribution.”

Demand

Hyderabad: No new competitor has opened a centre in Hyderabad

Narasimha Raju · Chief Financial Officer · p. 18
“Amey, just to add to that, we haven't seen any new player opening a center in Hyderabad.”

Radiology: Shift to high-end radiology such as CT angio

Narasimha Raju · Chief Financial Officer · p. 8
“Because we have seen there is a movement even in radiology from basic radiology modalities to high-end radiology modalities like CT, including like CT angio cases, etc.”

Hyderabad: Faster ramp-up of spokes in Western Hyderabad

Sunil Chandra Kondapally · Executive Director · p. 4
“We are witnessing particularly strong traction and faster ramp-up across our spoke centers in Western Hyderabad, mainly supported by the residential and commercial development, including it being the IT and financial district.”

Bengaluru: New Bengaluru centres see early footfall mainly for high-end MRI and CT

Narasimha Raju · Chief Financial Officer · p. 21
“Here, since we added high-end radiology equipment, initially we see more footfall in this newer geography, say for example, HSR Layout, Yelahanka, towards your high-end MRI cases, CT cases, etc, not for the regular”

Margins and costs

Q2 EBITDA margin 44.1%, up 350 bps, driven by operating leverage

Narasimha Raju · Chief Financial Officer · p. 6
“Our EBITDA margin stood healthy at 44.1%, reflecting an improvement of 350 basis points over the corresponding quarter of last year, primarily driven by operating leverage.”

No price hike yet this year; may decide in Q3 or Q4

Narasimha Raju · Chief Financial Officer · p. 9
“We have not yet done the price hike. We will see whether we will do it in Q3 or Q4.”

65-70% of expenses fixed; operating leverage when growth exceeds 15-18%

Narasimha Raju · Chief Financial Officer · p. 10
“close to like a 65%-70% of our expenses are fixed in nature, which is allowing this operating leverage to play out whenever revenue is growing beyond that 15% to 18%.”

About 2% margin benefit in Q2 from CGHS tariff hike

Narasimha Raju · Chief Financial Officer · p. 10
“Apart from that, in the current quarter, there is a benefit of close to like a 2% benefit would have been there because of the CGHS tariff hike also.”

No significant margin drag from the 10 hubs added last year

Sunil Chandra Kondapally · Executive Director · p. 17
“Even though it was 10 hubs in one year, we have not seen any significant drag on margins.”

Debt and working capital

Surplus cash about Rs 355 crore

Narasimha Raju · Chief Financial Officer · p. 7
“We continue to maintain a strong balance sheet with a surplus cash position of approximately INR 355 crore.”

Acquisitions and new business

Agreement signed to acquire Arya Wellness Centre, Guwahati; entry into Northeast

Sunil Chandra Kondapally · Executive Director · p. 5
“During the quarter, we also entered into a business transfer agreement to acquire Arya Wellness Centre in Guwahati, Assam, and this marks our entry into the Northeast region and is an important step towards expanding our presence beyond our existing markets.”

Arya Wellness deal expected to complete in the next two months

2​months
Narasimha Raju · Chief Financial Officer · p. 6
“Currently, we are in the process of completing the CPs as per the terms of this BTA, and we expect that this transaction will be completed in the next two months.”

Arya Wellness has revenue of more than Rs 25 crore, fully B2C

Narasimha Raju · Chief Financial Officer · p. 16
“It is a good quality asset that we propose to acquire with top line of more than INR 25 crore and fully focused on B2C, just like Vijaya, and again doing high-end work across pathology and radiology.”

Arya Wellness EBITDA margin above 20% (pre-Ind AS)

Narasimha Raju · Chief Financial Officer · Q&A · p. 17
“It is currently doing close to above 20% EBITDA, and that too, it is pre-Ind AS EBITDA that I am talking is, they are doing almost close to more than 20%.”

No new geography planned beyond Assam; open to fitting M&A

Narasimha Raju · Chief Financial Officer · p. 11
“As of now, we are not expecting any other further geography, but down the line, in case if we get any interesting M&A acquisition opportunity in new geography, which will fit into our M&A strategy, then definitely we will be open to explore those options as well.”

Other

Q2 revenue about Rs 255 crore, up 26.7% year-on-year

Narasimha Raju · Chief Financial Officer · p. 5
“Consolidated revenue for the current quarter stood at approximately INR 255 crore, registering a strong year-on-year growth of 26.7%.”

Q2 growth driven by 16.5% volume growth, test mix and CGHS tariff revision

Narasimha Raju · Chief Financial Officer · p. 5
“This growth was primarily driven by test volume growth of 16.5% year-on-year and a favorable change in test mix, and also the revision in CGHS tariffs.”

Growth split: about 3% CGHS tariff, 4-5% test mix, about 16.5% volume

Narasimha Raju · Chief Financial Officer · Q&A · p. 9
“So, 3% can be attributable to that, 4%-5% on account of favorable change in test mix, and around 16%, 16.5% is the volume growth.”

Q2 EBITDA about Rs 113 crore vs Rs 82 crore, up 37.8%

Narasimha Raju · Chief Financial Officer · p. 6
“EBITDA for the current quarter stood at approximately INR 113 crore compared to INR 82 crore in the corresponding quarter of the previous year, registering a strong year-on-year growth of 37.8%.”

Q2 PAT Rs 59 crore, up 37.4%; PAT margin 23.3%

Narasimha Raju · Chief Financial Officer · p. 6
“Profit after tax for the current quarter stood at INR 59 crore, registering a growth of 37.4% year-on-year, with a PAT margin of 23.3%.”

Sources

Management's own statements, quoted from its NSE filings. This page was read by AI and can contain mistakes: check the source pages before relying on any figure. No forecast or opinion of ours. Not investment advice.

Search

Search funds, ETFs, stocks, pages and tools